Invadopodia: Unique methods for measurement of extracellular matrix degradation in vitro

Methods in Cell Biology

Volumn , Issue 63, 2001, Pages 613-627

  Bowden, Emma T ^a   Coopman, Peter J ^a,b   Mueller, Susette C ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; GELATIN;

ARTICLE; BREAST TUMOR; CANCER INVASION; CELL CULTURE; CELL MOTION; CELL SEPARATION; CELL SURFACE; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; HUMAN; METABOLISM; METHODOLOGY; PHAGOCYTOSIS; PHYSIOLOGY;

BREAST NEOPLASMS; CELL MOVEMENT; CELL SEPARATION; CELL SURFACE EXTENSIONS; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GELATIN; HUMANS; NEOPLASM INVASIVENESS; PHAGOCYTOSIS; TUMOR CELLS, CULTURED;

EID: 0035227262     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(01)63033-4     Document Type: Article

References (29)

1. 3H-methyl]collagen. J. Biochem. Biophys. Methods 5, 147-152.
2. Bjerknes, R., Bjerkvig, R., and Laerum, O. D. (1987). Phagocytic capacity of normal and malignant rat glial cells in culture. J. Natl. Cancer Inst. 78, 279-288.
3. Bowden, E. T., Barth, M., Thomas, D., Glazer, R. I., and Mueller, S. C. (1999). A novel association of cortactin, paxillin, and PKCμ with invasive and motile membranes. Oncogene 18, 4440-4449.
4. Chen, W.-T. (1996). Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49, 59-71.
5. Chen, W.-T., Olden, K., Bernard, B. A., and Chu, F.-F. (1984). Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites. J. Cell Biol. 98, 1546-1555.
6. Chen, W.-T., Chen, J. M., Parsons, S. J., and Parsons, J. T. (1985). Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature 316, 156-158.
7. Coopman, P. J., Thomas, D. M., Gehlsen, K. R., and Mueller, S. C. (1996). Integrin α3β1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol. Biol. Cell 7, 1789-1804.
8. Coopman, P. J., Do, M. T. H., Thompson, E. W., and Mueller, S. C. (1998). Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin. Cancer Res. 4, 507-515.
9. Hendrix, M. J., Seftor, E. A., Seftor, R. E., Misiorowski, R. L., Saba, P. Z., Sundareshan, P., and Welch, D. R. (1989). Comparison of tumor cell invasion assays: Human amnion versus reconstituted basement membrane barriers. Invasion Metastasis 9, 278-297.
10. Imamura, F., Horai, T., Mukai, M., Shinkai, K., and Akedo, H. (1991). Serum requirement for in vitro invasion by tumor cells. Jpn. J. Cancer Res. 82, 493-496.
11. Itoh, K., Yoshioka, K., Akedo, H., Uehata, M., Ishizaki, T., and Narumiya, S. (1999). An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 5, 221-225.
12. Kelly, T., Mueller, S. C., Yeh, Y., and Chen, W.-T. (1994). Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell Physiol. 158, 299-308.
13. Le, M. N., and Bruyneel, E. (1996). Comparison of in vitro invasiveness of human breast carcinoma in early or late stage with their malignancy in vivo. Anticancer Res. 16, 2767-2772.
14. r 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res. 53, 3159-3164.
15. Monsky, W. L., Lin, C.-Y., Aoyama, A., Kelly, T., Mueller, S. C., Akiyama, S. K., and Chen, W.-T. (1994). A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 54, 5702-5710.
16. Montcourrier, P., Mangeat, P. H., Valembois, C., Salazar, G., Sahuquet, A., Duperray, C., and Rochefort, H. (1994). Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J. Cell Sci. 107, 2381-2391.
17. 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc. Natl. Acad. Sci. U.S.A. 91, 8856-8860.
18. Mueller, S. C., and Chen, W.-T. (1991). Cellular invasion into matrix beads: Localization of β 1 integrins and fibronectin to the invadopodia. J. Cell Sci. 99, 213-225.
19. Mueller, S. C., Yeh, Y., and Chen, W.-T. (1992). Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol. 119, 1309-1325.
20. Nakahara, H., Nomizu, M., Akiyama, S. K., Yamada, Y., Yeh, Y., and Chen, W.-T. (1996). A mechanism for regulation of melanoma invasion. Ligation of α6β1 integral by laminin G peptides. J. Biol. Chem. 271, 27221-27224.
21. Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y. Y., and Chen, W. T. (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. U.S.A. 94, 7959-7964.
22. RhoGAP and membrane-protrusive activities at invadopodia. J. Biol. Chem. 273, 9-12.
23. Ruoslahti, E. (1992). The Walter Herbert Lecture. Control of cell motility and tumour invasion by extracellular matrix interactions. Br. J. Cancer 66, 239-242.
24. Shaw, L. M., Chao, C., Wewer, U. M., and Mercurio, A. M. (1996). Function of the integrin α6β1 in metastatic breast carcinoma cells assessed by expression of a dominant negative receptor. Cancer Res. 56, 959-963.
25. Staebler, A., Sommers, C., Mueller, S. C., Byers, S., Thompson, E. W., and Lupu, R. (1994). Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin]. Breast Cancer Res. Treat. 31, 175-182.
26. Van Peteghem, M. C., Mareel, M. M., and De Bruyne, G. K. (1980). Phagocytic capacity of invasive malignant cells in three-dimensional culture. Virch. Arch. B. Cell Pathol. Incl. Mol. Pathol. 34, 193-204.
27. Waller, C. A., Braun, M., and Schirrmacher, V. (1986). Quantitative analysis of cancer invasion in vitro: Comparison of two new assays and of tumour sublines with different metastatic capacity. Clin. Exp. Metastasis 4, 73-89.
28. Xu, F. J., Stack, S., Boyer, C., O'Briant, K., Whitaker, R., Mills, G. B., Yu, Y. H., and Bast, R. C. J. (1997). Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): Increased invasiveness may contribute to poor prognosis. Clin. Cancer Res. 3, 1629-1634.
29. Zucker, S., Lysik, R. M., Ramamurthy, N. S., Golub, L. M., Wieman, J. M., and Wilkie, D. P. (1985). Diversity of melanoma plasma membrane proteinases: Inhibition of collagenolytic and cytolytic activities by minocycline. J. Natl. Cancer Inst. 75, 517-525.